Toward the end of trading Monday, the Dow traded up 5.88% to 22291.21 while the NASDAQ rose 5.76% to 7,797.89. The S&P also rose, gaining 5.77% to 2,632.30.
The U.S. is now the epicenter of the coronavirus pandemic with the highest number of cases around the world. U.S. reported a total of 337,600 coronavirus cases with around 9,600 deaths. Spain confirmed a total of over 131,600 coronavirus cases with 12,600 deaths, while Italy reported a total of at least 128,900 confirmed cases and 15,800 deaths. In total, there were at least 1,280,000 cases of COVID-19 worldwide with over 69,700 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Utilities shares climbed 7.9% on Monday. Meanwhile, top gainers in the sector included CenterPoint Energy, Inc. CNP 12.43%, up 12%, and Evergy, Inc. EVRG 11.33%, up 12%.
In trading on Monday, consumer staples shares rose by just 2.8%.
Top Headline
Simply Good Foods Co SMPL 7.67% reported better-than-expected results for its second quarter.
Simply Good Foods reported quarterly earnings of $0.23 per share, beating analysts’ estimates of $0.18 per share. The company’s sales came in at $227.1 million, exceeding the consensus view of $220.9 million.
Equities Trading UP
Immunomedics, Inc. IMMU 96.38% shares shot up 96% to $18.42 after the company said it would stop its Ascent Study due to compelling evidence of efficacy.
Shares of XpresSpa Group, Inc. XSPA 7.8% got a boost, shooting 46% to $0.3173 after jumping over 31% on Friday. The company is converting its airport spa locations into testing locations.
Wayfair Inc W 38.13% shares were also up, gaining 39% to $70.14 after the company said it expects to meet or exceed its previously announced guidance. Wayfair reported private placement of $535 million of convertible senior notes.
Equities Trading DOWN
Millendo Therapeutics Inc MLND 70.1% shares tumbled 68% to $1.55 after the company announced its phase 2b trial did not achieve statistically significant results.
Shares of Menlo Therapeutics Inc MNLO 47.49% were down 48% to $1.3350 after the company announced two phase 3 trials did not achieve their primary endpoints.
OncoSec Medical Incorporated ONCS 17.82% was down, falling 16% to $1.69. OncoSec reported collaboration with providence cancer institute to conduct first-in-human trial of its CORVax12 investigational vaccine as prevention for coronavirus.
Commodities
In commodity news, oil traded down 6.2% to $26.59, while gold traded up 3.1% to $1,696.80.
Silver traded up 4.5% Monday to $15.14, while copper rose 0.9% to $2.2125.
Euro zone
European shares closed higher today. The eurozone’s STOXX 600 rose 3.73 % the Spanish Ibex Index rose 3.99%, while Italy’s FTSE MIB Index climbed 4%. Meanwhile, the German DAX gained 5.77%, and the French CAC 40 rose 4.61% while UK shares rose 3.08%.
Economics
On the economics calendar Monday, there is no important data due out.
Benzinga does not provide investment advice. All rights reserved.
Recommended Content
Editors’ Picks
EUR/USD edges lower toward 1.0700 post-US PCE
EUR/USD stays under modest bearish pressure but manages to hold above 1.0700 in the American session on Friday. The US Dollar (USD) gathers strength against its rivals after the stronger-than-forecast PCE inflation data, not allowing the pair to gain traction.
GBP/USD retreats to 1.2500 on renewed USD strength
GBP/USD lost its traction and turned negative on the day near 1.2500. Following the stronger-than-expected PCE inflation readings from the US, the USD stays resilient and makes it difficult for the pair to gather recovery momentum.
Gold struggles to hold above $2,350 following US inflation
Gold turned south and declined toward $2,340, erasing a large portion of its daily gains, as the USD benefited from PCE inflation data. The benchmark 10-year US yield, however, stays in negative territory and helps XAU/USD limit its losses.
Bitcoin Weekly Forecast: BTC’s next breakout could propel it to $80,000 Premium
Bitcoin’s recent price consolidation could be nearing its end as technical indicators and on-chain metrics suggest a potential upward breakout. However, this move would not be straightforward and could punish impatient investors.
Week ahead – Hawkish risk as Fed and NFP on tap, Eurozone data eyed too
Fed meets on Wednesday as US inflation stays elevated. Will Friday’s jobs report bring relief or more angst for the markets? Eurozone flash GDP and CPI numbers in focus for the Euro.